ข่าวประชาสัมพันธ์GlaxoSmithKline | newswit

GSK Participates in the British Embassy's Re-imagining UK Aging Care Event with a Focus on Enhancing Adult Immunization – Ms. Marija Krstic, 19 Apr

Marija Krstic Appointed as General Manager for GSK Thailand – Marija, who has been with GSK since 2004, brings over two decades of expertise gained 04 Dec

GSK partners with True Group to enhance medical services for respiratory disease patients through EACCs by launching Telehealth Together – Assoc. Oct 2021

Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX(R) (Sumatriptan Nasal Spray, 20 mg) – Cipla's Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline's Imitrex(R) Nasal Spray.Imitrex(R) Nasal Spray is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults.According to

Cipla ได้รับการอนุมัติขั้นสุดท้าย เพื่อวางจำหน่าย Sumatriptan Nasal Spray, 20 mg ยาสามัญที่มีต้นแบบจาก IMITREX(R) ของ GlaxoSmithKline – Sumatriptan Nasal Spray USP, 20 mg ของ Cipla เป็นยาสามัญกลุ่ม AB ที่มีต้นแบบจาก Imitrex(R) Nasal Spray ของบริษัท GlaxoSmithKlineImitrex(R) Nasal Spray เป็นยากลุ่ม triptan ซึ่งมีฤทธิ์ต้านเซโรโทนิน (5-HT1B/1D) สำหรับใช้รักษาอาการไมเกรนทั้งที่มีหรือไม่มีอาการเตือนในผู้ใหญ่ข้อมูลจาก IQVIA (IMS

Photo Release: GSK donates one million baht to the Siriraj Foundation for medical supplies to fight against COVID-19 – Apr 2020

GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets – Dominique Limet, CEO, ViiV Healthcare, said: "As a result of these transactions, ViiV Healthcare now has one of the most robust HIV pipelines in the industry. The assets that we have acquired complement our existing portfolio and could lead to new medicines and combinations addressing a broad range of

Photo Release: GSK receives award for Good Corporate Governance 2014 – GSK is the only company in the Thai pharmaceutical industry to win the Good Corporate Governance award, which recognizes the company’s good governance that adheres to the principles of accountability and responsibility, transparency, and following a Code of Conduct and Code of Ethics. GSK’s strong sense of corporate responsibility is further

Boehringer Ingelheim and GlaxoSmithKline Back EFA's Call for Urgent Improvements in Care for People With Lung Disease This World COPD Day – Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have today announced their support of The European Federation of Allergy and Airways Diseases Patients' Associations' (EFA) call for urgent

แกล็กโซสมิธไคลน์ คอนซูเมอร์ เฮลท์แคร์ เล็งเผยแพร่ผลิตภัณฑ์นิโคตินช่วยเลิกบุหรี่ หวังเจาะกลุ่มนักสูบ 85% ทั่วโลก – ผู้เชี่ยวชาญจากทั่วโลกมารวมตัวกันที่การประชุมการควบคุมยาสูบโลก เพื่อถกประเด็นการลดจำนวนผู้สูบบุหรี่และเพิ่มโอกาสในการเข้าถึงการรักษาแกล็กโซสมิธไคลน์ คอนซูเมอร์ เฮลท์แคร์ (Glaxosmithkline Consumer Healthcare หรือ GSK) ประกาศเผยแพร่ผลิตภัณฑ์นิโคตินเพื่อการเลิกบุหรี่ หวังเข้าถึงผู้สูบบุหรี่กว่า 800 ล้านคนทั่วโลกภายใน 4

GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the World's Smokers with Quit Aids – Experts convene at World Conference on Tobacco OR Health meeting to discuss reducing global tobacco use and accessibility to treatment options GlaxoSmithKline (GSK) Consumer Healthcare today announced plans to increase the availability of their therapeutic nicotine products to reach more than 800 million people world-wide over the

GlaxoSmithKline To Make Unprecedented Vaccine Donation To WHO Pandemic Flu Stockpile – Bangkok--10 Aug--BrandComm Consultants GlaxoSmithKline (GSK) recently announced its intention to donate 50 million doses of H5N1 adjuvanted pre-pandemic influenza vaccine to the World Health Organization (WHO) in support of its stockpile initiative. The donation will help establish a much needed stockpile of pre-pandemic vaccines that can be

AsiaNet Daily Summary - Press Releases for Monday, January 8, 2007 – PEPTECH ANNOUNCES...SYDNEY: Australian biotechnology company Peptech Limitedannounces that the acquisition by GlaxoSmithKline plc ofDomantis, the UK drug development company in which Peptech helda 31.02 per cent fully diluted interest, has been completed.www.peptech.comFUNDING INCREASE...NASSAU, Bahamas: Global Environmental Energy Corp

GSK launches interactive The Mobile Health Advisory Campaign to enhance health awareness – Bangkok--Sep 13--GlaxoSmithKline (Thailand) GlaxoSmithKline (Thailand) Co., Ltd. today launched the "Mobile Health Advisory Campaign" which is a part of its public educational programmes worth 50 million baht aimed at making Thais aware of healthy living. The launch at Siam Discovery Centre, was presided over by HE Minister of Public